Sensus Healthcare Q1 revenue $10.3M (+237% YoY); net income $0.97/share; launches new product, share buyback

Sensus Healthcare, Inc.

2022-Q1 EPS reported $0.97 revenue$10,338,000

Revenue $10.3M, up 237% YoY; net income $16.1M ($0.97 diluted) vs net loss $1.1M.
Adjusted EBITDA $16.9M vs $(0.8M); gross margin expanded to 69.1% from 51.6%.
Sold non-core asset for $15.0M cash, recorded $12.8M gain; launched TransDermal Infusion product.
Board approved $3.0M share repurchase program; cash balance $32.8M.
Affirms Q2 and FY 2022 profitability expectations.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.